1-Acyl-2-lysophosphatidylcholine transport across the blood—retina and blood—brain barrier  by Alberghina, Mario et al.
FEBS Letters 351 (1994) 181-185 
FEBS 14424 
1-Acyl-2-1ysophosphatidylcholine transport across the blood-retina 
blood-brain barrier 
Mario Alberghina*, Salvatore Infarinato, Carmelina D. Anfuso, Gabriella Lupo 
Institute of Biochemistry, Faculty of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy 
Received 7 June 1994; revised version received 14 July 1994 
and 
Abstract 
The transport of lysophospholipids through the rat blood-retina nd blood-brain barrier was determined by using radioactive l-palmitoyl-2- 
lysophosphatidylcholine (Pam-lysoPtdCho) and by measuring the uptake of this labeled compound into the retina and various brain regions after 
short in situ carotid perfusion. The transport was not affected by probenecid (0.25 mM), but it was inhibited, in a dose-dependent manner, by 
circulating albumin which is able to bind tightly to lysophosphatidylcholine and lowered the availability of the latter for tissue xtraction. Radiotracer 
transfer in the retina was higher than in brain regions. The permeability-surface r a products (PS) changed with the inclusion of unlabeled 
Pam-lysoPtdCho, showing that transport across retinal and brain microvessels is mainly saturable. The data provided an estimate of transport 
constants (Vmax, Km and non-saturable constant Kd). However, we could not distinguish whether this saturable process represents he saturation of 
a transport carrier or simple passive diffusion followed by the saturation of enzymatic reactions. In brain tissue lipid extract, 20 s after carotid injection, 
radiolabel was associated by 45% to unmetabolized Pam-lysoPtdCho. Partial acylation to phosphatidylcholine, as well as hydrolysis and redistribution 
of the fatty acyl moiety into main phospholipid classes also occurred. The present results, compared to our previous data, indicate that Pam- 
lysoPtdCho is transported faster and/or in greater amounts than unesterified fatty acids. 
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1. Introduction 
Lysophosphatidylcholine (lysoPtdCho) is a normal 
constituent o f  mammal ian plasma representing 5-20% of  
total phospholipids. In the rat, it is the second most 
prevalent plasma phospholipid with a concentration of  
0.20-0.25 mM [1,2]. In the blood, lysoPtdCho is com- 
plexed to albumin [3] and lipoproteins [2,4,5], and origi- 
nates from two metabolic pathways: (i) the transesterifi- 
cation of  PtdCho and free cholesterol catalyzed by an 
acyltransferase (LCAT), a reaction which is responsible 
for the more saturated lysoPtdCho species [6]; (ii) the 
direct secretion of  more unsaturated species by the liver 
[7-9]. In this organ, lysoPtdCho arises from the deacyla- 
tion o f  PtdCho by phospholipases A~ and A2. Plasma 
lysoPtdCho has been considered a transport form to 
tissues, and especially the brain, o f  both choline and 
unsaturated fatty acids [2,1 0-12]. 
The possibility of  lysoPtdCho transport into the brain 
is strongly suggested by several incorporation experi- 
ments. Labeled lysoPtdCho injected into the blood 
stream rapidly disappeared from the circulation and is 
mainly recovered in: (a) PtdCho isolated from several 
organs [13], including the brain [11]; (b) fatty acid frac- 
tion because of  hydrolysis catalyzed by tissue lyso- 
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lysophosphatidylcholine; Pam-lysoPtdCho, 1-palmitoyl-2-1ysophos- 
phatidylcholine; PtdCho, phosphatidylcholine; BRB, blood-retina bar- 
rier; BBB, blood-brain barrier. 
phospholipase activity, or (c) water-soluble degradation 
intermediates (choline, P-choline and betaine) because of  
extensive enzymatic fragmentation [11]. The uptake of 
intact, a lbumin-bound saturated and unsaturated 1-acyl 
or 2-acyl- lysoPtdCho by developing rat brain after intra- 
venous perfusion per 30 s has been demonstrated [2]. It 
is well known that both species turn over in the brain 
even if 2-acyl- lysoPtdCho is likely to be reacylated to 
form PtdCho more actively than the 1-acyl species [14]. 
Unsaturated 2-acyl- lysoPtdCho is taken up by total 
brain more efficiently than saturated ones or the corre- 
sponding unesterified fatty acids, even if the metabolic 
fate of  the liberated fatty acid in the brain is not exactly 
the same. However, Pardridge and co-workers [15] have 
questioned whether lysoPtdCho is able to cross the 
blood-brain barrier. The present experiments were per- 
formed to investigate whether: (i) 1-palmitoyl-lyso- 
PtdCho (Pam-lysoPtdCho) could be transported across 
the blood-brain barrier (BBB) and blood-ret ina barrier 
(BRB); (ii) fatty acids esterified to lysophospholipids are 
transported more or less efficiently than their unesteri- 
fled form. 
2. Materials and methods 
The uptake of 1-acyl-L-l-([l-~4C]palmitoyl)-2-1yso-sn-glycero-3 - 
phosphocboline across the capillaries of the retina, optic nerve, intra- 
cranial structures of the visual system (lateral geniculates, uperior 
colliculi, visual cortex) and other main brain CNS areas was measured 
in groups of Sprague-Dawley male rats aged 4 months. The in situ 
brain perfusion technique of Takasato et al. [16] was used as in our 
previous tudies [17,18], except that fatty acid-free bovine serum albu- 
min (BSA, at the concentrations 0-1.0 mM) and no Ca 2÷ ions were 
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included in bicarbonate-based salt solution (HBSS). The medium, con- 
taining 142.0 NaC1, 28.0 NaHCO3, 4.2 KH2PO4, 1.0 MgSO4 in/lmol/ml 
and 6 ,umol/ml glucose, was equilibrated with a gas mixture O2/CO 2 
(95:5%) at 37°C for 5 min. The pH was checked and 
equaled 7.4. Radioactive l-acyl-lysoPtdCho was dissolved in HBSS to 
give a 20ktM concentration i  the perfusate, with a specific radioactivity 
of 56 mCi/mmol (Amersham Int. plc, England). In a set of experiments, 
unlabeled 1-palmitoyl-lysoPtdCho (final concentration, 0.03 1.5 mM) 
was also added. In all experiments in which [taC]lysophosphatidyl- 
choline was used in the perfusion medium, [3H(G)]inulin (291 mCi/g, 
NEN-Du Pont) was included in the perfusate (3H/14C ratio 5: 1) in order 
to measure intravascular space. 
In brief, the technique involves cannulating with thin-wall polyethyl- 
ene catheter (PE-30) the left common carotid artery of animals anaes- 
thetized with continuous flow of O2/N20 gas mixture, containing 2% 
halothane during the initial surgery. The left external carotid artery, 
rostrally to the bifurcation from the common carotid, was tied off 
whereas the pterygopalatine branch was left open. At zero time, ha- 
lothane was discontinued and the common carotid artery was ligated; 
the perfusion of the internal carotid was begun at a constant rate by 
a perfusion pump and continued with HBSS solution for periods up to 
20 s. The temperature of the injectate was 35 37°C, and the perfusion 
rate was 83/d/s. During the short time of perfusion, the thorax of the 
animal was opened and the left ventricle of the heart was cut. At the 
end of the perfusion, the rats were decapitated, the eyes dissected and 
the brain, including the optic nerves, was removed from the skull and 
washed with ice-cold saline. The meninges and blood vessels on the 
surface of each brain region were carefully removed while on a chilled 
metal platform, and the various brain regions of the perfused side were 
dissected out, weighed on chilled filter paper moistened with saline and 
digested overnight at 50°C in 1 ml Soluene 100 (Packard, Ill.). Two 
hours after a bleaching process with a few drops of 35% H20:, they were 
prepared to be assayed for radioactivity in a scintillation counter by the 
addition of 10 ml of Instagel (Packard, I11.). Desheathed optic nerves 
and retinas were also collected from the left eye bulbs, and processed 
as previously described [17]. Perfusate flow (F) through the brain re- 
gions was measured using [methyl-3H]diazepam (84.2 mCi/mmmol, 
NEN-Du Pont). The perfusion rate was 83 ,ul/s and the perfusion time 
was 7 s. F and PS were determined from the relative equations as 
described by Takasato et al. [16]. The same calculations have also been 
applied recently by us to characterize fatty acid transport across BRB 
and BBB of the rat [17,18]. Assuming that the flux data could be 
described by a Michaelis-Menten transport model, unidirectional in- 
flux J,, was estimated by fitting the data to the following equation: 
Ji,1 = F(1--e-eS/F)Cpr , where Cpf is the perfusate concentration of Pam- 
lysoPtdCho. Vma xand K m constants (the maximal transport rate of the 
saturable component, and the half-saturation constant of the saturable 
component) were obtained by using an Eadie Hofstee transformation 
of the J,,, and Pam-PtdCho concentration data. Ka, the constant of 
non-saturable transport, was estimated by employing the equation: 
PS = Vmax/(Km + Cpf) + K d, reported by Smith et al. [19] for amino acid 
brain perfusion. 
3. Results 
Table 1 shows the results indicating that the control 
(no albumin was added to the carotid perfusate) PS 
index of blood-to-CNS Pam-lysoPtdCho transport was 
higher for the optic nerve and tract, cortex, hippocampus 
and olfactory bulb than for other white or gray matter 
areas. For the other transport index, i.e. the radioactivity 
ratio which broadly indicates the parenchymal penetra- 
tion of [14C]lysoPtdCho compared to that of undiffusible 
[3H]inulin, the highest values belong to the retina and 
parietal-frontal cortex. This differentiated regional pro- 
file in lysophospholipid transport partially parallels the 
blood perfusate flow values measured by [3H]diazepam 
injection [1]. Table 1 also shows that, in any CNS region, 
Pam-lysoPtdCho uptake (radioactivity ratio and PS 
product) was not inhibited by probenecid. Linoleic acid 
also enters the brain from the blood by a probenecid- 
insensitive mechanism [24]. The presence of 14 ~tM albu- 
min (physiological concentration i the rat plasma) in 
the carotid artery injection solution inhibited radioactiv- 
ity ratios, bringing about significant inhibition of PS 
Table 1 
Retinal and cerebrovascular uptake ratios and capillary permeability-surface ar a 
nervous ystem regions of rats 
(PS) products for 1-acyl-L-l-([1-~4C]palmitoyl]-2-1ysoPtdCho in 
Regions Ratios" PS (s-I.104) 
Controls Probenecid 14/tM BSA Controls Probenecid 14/tM BSA 
(no BSA) (0.25 raM, no BSA) (no BSA) (0.25 mM, no BSA) 
Retina 44.9 + 8.3 38.8 + 7.3* 35.0 _+ 8.4 28.8 _+ 6.9 23.9 + 5.5* 12.7 _+ 3.7 *b 
Optic nerve 17.9 + 3.7 15.3 + 3.9 17.7 + 2.9 39.7 + 8.7 35.6 _+ 5.7 12.8 + 3.9 *b 
Optic tract 16.6 _+ 1.6 15.4 + 4.9 7.94 + 2.0* 54.0 + 10 60.0 + 15 26.1 _+ 8.8 *h 
Lateral geniculate 23.8 _+ 3.7 25.5 + 5.6 21.3 +_ 6.4 27.7 + 7.4 22.9 + 6.3 25.1 + 7.4 
Superior colliculus 20.0 _+ 4.9 24.1 + 3.4 19.9 + 5.3 25.2 + 5.4 17.9 + 4.5 23.5 _+ 6.3 
Visual cortex 25.8 _+ 5.2 28.1 + 8.7 21.7 + 6.5 51.6 + 9.9 60.0 + 8.0 28.7 + 8.3 *b 
Parietal cortex 44.3 _+ 9.4 22.5 + 3.4* 17.5 _+ 2.6* 32.1 + 6.3 38.5 + 9.6 20.8 + 7.2 
Frontal cortex 49.5 + 6.7 20.9 + 6.5* 16.4 _+ 4.3* 27.0 + 4.0 26.0 + 7.2 25.3 + 6.4 
Striatum 29.9 + 4.0 30.7 + 9.1 22.9 + 6.0 29.3 _+ 4.7 36.0 _+ 9.1 12.1 _ 4.0 *b 
Hippocampus 17.5 +_ 4.0 21.6 _+ 6.4 17.0 + 3.2 39.3 + 9.2 36.1 _+ 0.2 13.0 _+ 0.0 *h 
Olfactory bulb 15.1 _+ 2.2 17.5 _+ 4.9 14.9 + 4.7 41.8 _+ 8.3 48.3 +_ 9.1 10.8 _+ 3.2 *u 
Data are means + S.E.M., with n = 3. The PS products were determined with 20 ,uM l-acyl-L-l-([1-~4C]palmitoyl)-2-1ysoPtdCho and 20 pg/ml 
[3H]inulin in the perfusate, at 20 s after internal carotid perfusion, using the standard assumptions and equation 9 ofTakasato et al. [16]. The perfusion 
rate was 83 ~tl/s. Statistical significance of differences between probenecid or 14 ~M bovine serum albumin (BSA) and control group (no BSA) was 
compared by Student's t-test, *P < 0.05. One way analysis of variance was also done, followed by Duncan's or Newman-Keuls '  multiple comparison 
tests, using NCSS version 4.21 (Dr. J.L. Hintze, Kaysville, Utah, USA) statistical software package to identify the changes that were significantly 
different from control values; bp < 0.05. 
aEach value represents the [~4C]lysoPtdCho/[3H]inulin ratio in the tissue of a given region divided by the same ratio in the perfusate. 
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Fig. 1. Permeability-surface area product (PS) at 20 s after carotid 
injection of 1-acyl-L-l-([1-'4C]palmitoyl)-2-1ysoPtdCho as function of 
free fatty acid bovine serum albumin concentration i the perfusate. 
Values for retina and three representative brain areas were reported. 
Data are mean + S.E.M. (n = 3 rats). 
products in the retina, optic nerve and tract, visual cortex 
and prosencephalic structures. With 5 mM Pam- 
lysoPtdCho in the perfusate, we did not observe any 
simple diffusion through the BRB and BBB. 
Fig. 1 shows plots of PS products vs. albumin concen- 
tration for four selected CNS areas. The results for other 
regions (see Table 1) were quite similar. The addition of 
albumin to the perfusate inhibited the rate of radiotracer 
uptake by both the retina and brain regions. This inhibi- 
tion can be explained simply by the binding of 
lysoPtdCho to albumin, leading to a decrease in the con- 
centration of free lysocompound in the medium. These 
results are similar to those of Pardridge and Mietus [21], 
who found that the uptake of palmitate by the brain was 
a function of the fatty acid-to-albumin ratio, and hence 
of the concentration f the unbound fatty acid. 
In all the regions studied, PS values decreased as a 
function of the increased concentration of unlabeled 
Pam-lysoPtdCho. With 5 mM in the perfusate, we did 
not observe any simple diffusion through the BRB or 
BBB. Fig. 2 illustrates the concentration dependence of
Pam-lysoPtdCho influx into the retina and one represen- 
tative brain area (parietal cortex). From the best-fit curve 
of Ji, data, calculated from PS and Cpf (perfusate con- 
centration of lysoPtdCho) values, plotted as a function 
of concentration, data for Vmax and Km were obtained. 
Table 2 presents mean values of the transport constants 
for each of the nine CNS regions examined in this study. 
There were marked regional differences in all three ki- 
netic parameters. Vma x mean values in the optic nerve and 
tract were two-to-three-fold greater than values in the 
retina and other brain regions. Among the regions, Km 
varied approximately 6-fold, whereas Kd values were low 
(of the order of 10 -5 ml/s/g), except for the optic nerve- 
tract and olfactory bulb, indicating that a non-saturable 
component of Pam-lysoPtdCho transport (accumulation 
of unmetabolized lysoPtdCho), if any, is hardly detecta- 
ble. 
Pooled brain areas from rats, injected for 20 s with 
[]4C]lysoPtdCho solution without or with 14 pM albu- 
min, were extracted with chloroform/methanol (2: 1, v/v), 
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Fig. 2. Concentration dependence of 1-palmitoyl-lysoPtdCho total influx into the retina and one representative brain area (parietal cortex) during 
perfusion with HBSS medium. Inset: Eadie-Hofstee plot for the graphical determination of Fmax and Kin. The values so obtained, together with PS 
data, were used to determine by the equation 4 of Smith et al. [19]. Kd, i.e. the constant describing the non-saturable uptake reported in Table 2. 
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and lipid extracts were processed and fractionated as 
previously described [22]. The radioactivity distribution 
among metabolic products was as follows: aqueous 
phase, 10.1%; neutral ipids and free fatty acids, 14.8%; 
lysoPtdCho, 45.4%; PtdCho, 22.1%; other phospholip- 
ids, 7.5%. 
4. Discussion 
The long-term objective of our work is to determine 
the mechanism by which lipid substances are transported 
through BBB or BRB. This study presents a quantitative 
analysis of Pam-lysoPtdCho transport across the BRB 
and BBB of the rat. Our results demonstrate that Pam- 
lysoPtdCho is able to cross retinal and cerebral micro- 
vasculature, and that the uptake is dependent on the 
albumin concentration of the perfusion medium. The 
apparent ransport affinity is region-dependent. At the 
same BSA concentration, Pam-lysoPtdCho showed 
higher PSs  than palmitate or docosahexaenoate [17,18]. 
Km values were approximately 45-fold greater than those 
for palmitate in myocytes [23], higher than those for 
neutral amino acids such as phenylalanine or trypto- 
phan, but similar to those of valine and threonine [19]. 
One consequence of the high Km values (range 0.085--0.5 
mM), indicative of a lower Pam-lysoPtdCho transport 
affinity at the BRB and BBB, is that the transport system 
in the rat is not saturated with lysoPtdCho at normal 
plasma concentrations (0.2-0.25 mM), except during hy- 
percholesterolemia when lysoPtdCho plasma levels in- 
creased [11]. 
Retinal and cerebrovascular Pam-lysoPtdCho trans- 
port, from the plasma albumin complex to inside the 
Table 2 
Kinetic parameters for saturable (Vmax, Kin) and non-saturable (Ks) 
component of 1-acyl-L-l-([1-~4C]palmitoyl)-2-1ysoPtdCho transport 
into nervous ystem regions of rats 
Regions Vma x(nmol/s/g) Km ~M) K d (ml/s/g × 104) 
Retina 0.36 + 0.04 230 + 65 0.58 + 0.2 
Optic nerve 0.89 + 0.01 330 + 98 4.03 + 1.9 
Optic tract 0.97 + 0.02 305 + 66 5.50 + 2.1 
Lateral geniculate 0.58 + 0.01 180 + 45 0.62 + 0.2 
Superior colliculus 0.32 + 0.06 95 + 21 0.91 + 0.3 
Parietal cortex 0.39 + 0.09 85 + 19 1.30 -+ 0.4 
Striatum 0.37 + 0.07 210 + 61 0.92 + 1.0 
Hippocampus 0.31 + 0.06 112 + 34 2.78 + 0.9 
Olfactory bulb 0.37 + 0.08 502 + 108 7.22 + 2.7 
Values (means +S.E.M., with n = 3) were obtained by fitting equations 
1 and 4 of Smith et al. [19] to PS data and 1-palmitoyl-lysoPtdCho 
concentrations i  the perfusate. The kinetic onstants were calculated 
from uptake values measured after 20 s. In a separate experiment, the 
uptake values were compared at 11 and 20 s, respectively. PS were 
found to be identical. Hence we assumed that the 20 s uptake values 
corresponded to initial uptake. 
endothelial cells and glia-neuron network, can be de- 
scribed quantitatively by a model that in principle in- 
cludes a saturable and non-saturable diffusion compo- 
nent. The multistep rocess could be quite similar to that 
hypothesized for fatty acids in heart myocytes [23]. Sub- 
strate transport across the luminal surface membrane 
implies dissociation from albumin in solution, transloca- 
tion, partial metabolic utilization across endothelial 
cells, transport through the abluminal endothelial mem- 
brane and extracellular matrix, and finally uptake by the 
glia-neuron plasma membrane prior to undergoing ter- 
minal, intracellular acylation-deacylation reactions. Our 
data cannot discriminate which step(s) of the long se- 
quence the kinetic constants refer to. However, consider- 
ing (i) the very small pool size of retinal and cerebral 
lysoPtdCho (in the rat retina, lysoPtdCho was undetect- 
able [25], and in the rabbit brain and rat cortex it ranged 
between 0.4 mol % and 3.1 weight % of total phospholip- 
ids, respectively [26,27]), (ii) its slight non-saturable com- 
ponent of uptake, and (iii) its fast metabolic transforma- 
tion, we favor the idea that simple membrane diffusion 
governs Pam-lysoPtdCho exchange across the endothe- 
lial membranes. 
The observed saturable component of uptake could be 
attributed to the sum of intracellular metabolic processes 
rather than the membrane transport carrier. The major 
metabolic pathways for the intracellular removal of lyso- 
phospholipids have been identified as: (i) reacylation by 
acyltransferase; (ii) transacylation of two lysophosphol- 
ipid molecules to form PtdCho, and (iii) hydrolysis by 
lysophospholipases to form free fatty acids and glycero- 
phosphoryl compounds. A survey of available kinetic 
data in the literature suggests that in CNS lysophosphol- 
ipids are rapidly converted into PtdCho (major meta- 
bolic route), and partially broken down to glycero- 
phosphoryl products and unesterified choline [11]. The 
apparent K m values for brain microsomal acyltransferase 
and transacylase were determined as 107 pM and 104 
/IM for 1-acyl-lysoPtdCho, with Vmax of 6.1 and 1.06 
nmol/min/mg, respectively [28,30]. In the rat retina, we 
reported an initial velocity of 0.67 nmol/min/mg for 
oleoylCoA:l-acyl-lysoPtdCho acyltransferase [29]. Rod 
outer segments revealed higher acyltransferase activity 
than that of lysophospholipase [20]. In addition, lyso- 
phospholipase A1 of rat brain membrane fraction 
showed a specific activity of 32.6 nmol/30 min/mg [31], 
and when purified from bovine brain it has a Vmax of 
0.55 pmol/min/mg [32]. 
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